The Pharma Pricing & Access Innovation Conference (PPIC) brings together pharmaceutical and biotechnology leaders, market access professionals, pricing strategists, health economists, and life sciences innovators to examine the evolving challenges of global pharmaceutical pricing and patient access. Hosted by EVERSANA, the conference provides a platform for industry knowledge exchange, strategic discussion, and practical insights into the commercial, regulatory, and economic forces shaping medicine access worldwide.
The conference explores key developments in pharmaceutical pricing, reimbursement strategies, health technology assessment, and global market access. Participants can examine international reference pricing, pricing policy changes, payer expectations, evidence generation, tender strategy, and the challenges of launching innovative therapies across different healthcare systems. These discussions help professionals understand how evolving regulations, economic pressures, and market dynamics influence pricing decisions and access pathways.
Innovation is a central focus of PPIC, with attention to the role of artificial intelligence, data analytics, forecasting, and digital solutions in improving pricing and market access decisions. Expert presentations, practical workshops, industry case studies, and interactive sessions provide opportunities to explore new approaches, exchange best practices, and address real-world challenges facing pharmaceutical and biotechnology organizations.
The event also encourages collaboration between commercial leaders, market access teams, healthcare stakeholders, and industry experts. Networking opportunities allow attendees to share experiences, build professional relationships, and gain perspectives on emerging trends across European and global pharmaceutical markets.
The Pharma Pricing & Access Innovation Conference is designed for professionals seeking to strengthen pricing strategies, navigate changing reimbursement environments, and support sustainable access to innovative medicines. By connecting industry expertise with practical solutions, PPIC contributes to ongoing discussions about the future of pharmaceutical commercialization and patient access.
